» Articles » PMID: 9811312

Oral Cancer Risk in Relation to Sexual History and Evidence of Human Papillomavirus Infection

Overview
Specialty Oncology
Date 1998 Nov 12
PMID 9811312
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Experimental models and analyses of human tumors suggest that oncogenic, sexually transmittable human papillomaviruses (HPVs) are etiologic factors in the development of oral squamous cell carcinoma (SCC). We conducted a population-based, case-control study to determine whether the risk of this cancer is related to HPV infection and sexual history factors.

Methods: Case subjects (n = 284) were 18-65-year-old residents of three counties in western Washington State who were newly diagnosed with oral SCC from 1990 through 1995. Control subjects (n = 477) similar in age and sex were selected from the general population. Serum samples were tested for HPV type 16 capsid antibodies. Exfoliated oral tissue collected from case and control subjects and tumor tissue from case subjects were tested for HPV DNA. Odds ratios (ORs) were calculated after adjusting for age, sex, cigarette smoking, and alcohol consumption.

Results: Among males only, oral SCC risk increased with self-reported decreasing age at first intercourse, increasing number of sex partners, and a history of genital warts. Approximately 26% of the tumors in case subjects contained HPV DNA; 16.5% of the tumors contained HPV type 16 DNA. The prevalence of oncogenic HPV types in exfoliated oral tissue was similar in case and control subjects. The ORs for HPV type 16 capsid seropositivity were 2.3 (95% confidence interval [CI] = 1.6-3.3) for all oral SCCs and 6.8 (95% CI = 3.0-15.2) for oral SCCs containing HPV type 16 DNA. The joint association of cigarette smoking and HPV type 16 capsid seropositivity with oral SCC (OR = 8.5; 95% CI = 5.1-14.4) was stronger than predicted from the sum of individual associations with current smoking (OR = 3.2; 95% CI = 2.0-5.2) and seropositivity (OR = 1.7; 95% CI = 1.1-2.6).

Conclusions: HPV type 16 infection may contribute to the development of a small proportion of oral SCCs in this population, most likely in combination with cigarette smoking.

Citing Articles

ABO blood types and head and neck cancer: a systematic review with meta-analysis of observational studies.

Shi H, Yao J, Jiang C, Xu W, Jiang Z, Chen Y BMJ Open. 2024; 14(10):e088016.

PMID: 39414296 PMC: 11481122. DOI: 10.1136/bmjopen-2024-088016.


Potential Transcript-Based Biomarkers Predicting Clinical Outcomes of HPV-Positive Head and Neck Squamous Cell Carcinoma Patients.

Munoz-Bello J, Romero-Cordoba S, Garcia-Chavez J, Gonzalez-Espinosa C, Langley E, Lizano M Cells. 2024; 13(13.

PMID: 38994960 PMC: 11240594. DOI: 10.3390/cells13131107.


Crosstalk between CAFs and tumour cells in head and neck cancer.

Li X, Gonzalez-Maroto C, Tavassoli M Cell Death Discov. 2024; 10(1):303.

PMID: 38926351 PMC: 11208506. DOI: 10.1038/s41420-024-02053-9.


Delaying age at first sexual intercourse provides protection against oral cavity cancer: a mendelian randomization study.

Sun T, He X, Chen X, Huaqing Y, Zhang H, Zhao M Front Oncol. 2024; 14:1361527.

PMID: 38699645 PMC: 11063229. DOI: 10.3389/fonc.2024.1361527.


De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy.

Yarbrough W, Schrank T, Burtness B, Issaeva N Viruses. 2024; 16(4).

PMID: 38675879 PMC: 11053602. DOI: 10.3390/v16040536.